# Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder

> **NCT02273154** · PHASE4 · UNKNOWN · sponsor: **Si Tianmei** · enrollment: 240 (estimated)

## Conditions studied

- Major Depression Disorder

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT02273154
- **Lead sponsor:** Si Tianmei
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2014-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02273154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02273154, "Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02273154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*